Salivary Gland Botulinum Toxin a Injections for Treating Sialorrhea Among Critically Ill Patients With Neurological Disorders.
TL;DR
Evaluating the safety and feasibility of using BoTN-A salivary injections to reduce sialorrhea in ANI patients highlights the safety and potential efficacy of salivary gland BoTN-A for reducing refractory sialorrhea among critically ill ANI patients.
OpenAlex 토픽 ·
Botulinum Toxin and Related Neurological Disorders
Cerebrospinal fluid and hydrocephalus
Neurological disorders and treatments
Evaluating the safety and feasibility of using BoTN-A salivary injections to reduce sialorrhea in ANI patients highlights the safety and potential efficacy of salivary gland BoTN-A for reducing refrac
APA
Fazila Aseem, Kayla John, et al. (2025). Salivary Gland Botulinum Toxin a Injections for Treating Sialorrhea Among Critically Ill Patients With Neurological Disorders.. The Neurohospitalist, 19418744251338148. https://doi.org/10.1177/19418744251338148
MLA
Fazila Aseem, et al.. "Salivary Gland Botulinum Toxin a Injections for Treating Sialorrhea Among Critically Ill Patients With Neurological Disorders.." The Neurohospitalist, 2025, pp. 19418744251338148.
PMID
40292333
Abstract
Sialorrhea is associated with various neurological conditions. Among critically ill patients with acute neurological injuries (ANI), sialorrhea leads to several adverse consequences, including extubation failure, inability to initiate non-invasive ventilation, aspiration pneumonia and prolonged hospitalization. Botulinum toxin (BoTN) injections can reduce salivary production. Both BoTN-A and BoTN-B are effective in managing sialorrhea among patients with neurogenic dysphagia. BoTN utilization for sialorrhea in critically ill adult ANI patients is not well-studied. The purpose of this study to evaluate the safety and feasibility of using BoTN-A salivary injections to reduce sialorrhea in ANI patients. In this case series, we retrospectively reviewed the off-label use of BoTN-A for sialorrhea in ANI patients at the University of North Carolina Neurosciences Intensive Care Unit. Study Sample: Six patients with ANI who received BoTNA treatment for neurogenic sialorrhea in absence of infection and medications with known side-effect of sialorrhea. For safety evaluation, we reviewed any documented adverse effects of BoTN-A injection. For efficacy, we evaluated the drooling severity, suctioning frequency, oxygen requirements, continued days on the ventilator, and pneumonia diagnoses. All patients had reduction in their documented drooling and suctioning requirements following BoTN-A injection. None had adverse events associated with BoTN-A injections. All patients experienced recurrent ventilator-associated pneumonias prior to BoTN-A injections whereas four patients had no pneumonia events after injections. Also, two patients were successfully weaned of oxygenation prior to discharge. This case series highlights the safety and potential efficacy of salivary gland BoTN-A for reducing refractory sialorrhea among critically ill ANI patients. Future studies are needed to evaluate whether sialorrhea reduction can lead to reduced hospital complications and overall length of hospital stay.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | Salivary
|
scispacy | 1 | ||
| 해부 | salivary gland
|
scispacy | 1 | ||
| 합병증 | infection
|
감염 | dict | 1 | |
| 약물 | BoTN-A
|
scispacy | 1 | ||
| 약물 | oxygen
|
C0030054
oxygen
|
scispacy | 1 | |
| 질환 | Sialorrhea
|
C0037036
Sialorrhea
|
scispacy | 1 | |
| 질환 | Neurological Disorders
|
C0027765
nervous system disorder
|
scispacy | 1 | |
| 질환 | critically ill
|
C0010340
Critical Illness
|
scispacy | 1 | |
| 질환 | acute neurological injuries
|
C0751792
Trauma, Nervous System
|
scispacy | 1 | |
| 질환 | ANI
→ acute neurological injuries
|
C0751792
Trauma, Nervous System
|
scispacy | 1 | |
| 질환 | pneumonia
|
C0032285
Pneumonia
|
scispacy | 1 | |
| 질환 | neurogenic dysphagia
|
C1955520
Neurogenic dysphagia
|
scispacy | 1 | |
| 질환 | neurogenic sialorrhea
|
scispacy | 1 | ||
| 질환 | drooling
|
C0013132
Drooling
|
scispacy | 1 | |
| 질환 | ventilator-associated pneumonias
|
C1701940
Pneumonia, Ventilator-Associated
|
scispacy | 1 | |
| 질환 | critically ill ANI
|
C0010340
Critical Illness
|
scispacy | 1 | |
| 기타 | BoTN-A
|
scispacy | 1 | ||
| 기타 | BoTN-B
|
scispacy | 1 | ||
| 기타 | BoTN-A salivary
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.